All Stories

  1. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

    Article • American Journal of Transplantation, December 2019, Wiley

    Dr Francisco M Marty

  2. A Phase II, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

    Article • Clinical Infectious Diseases, December 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  3. Use of triazoles for the treatment of invasive aspergillosis: A three‐year cohort analysis

    Article • Mycoses, October 2019, Wiley

    Dr Francisco M Marty

  4. Development of a Set of Lupus‐Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study

    Article • Arthritis Care & Research, October 2019, Wiley

    Dr Francisco M Marty

  5. Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

    Article • Medical Mycology, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  6. Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2019, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  7. Long-term Persistence of an Extensively Drug-Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  8. Reply to Singh

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  9. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals

    Article • Journal of Antimicrobial Chemotherapy, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  10. 1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  11. 2453. Prolonged Local Epidemic of an XDR P. aeruginosa Subclade of High-Risk Clonal Complex 298

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  12. 2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  13. 269. Epidemiology and Outcomes of Invasive Aspergillosis (IA) Among Pediatric Immunocompromised Patients: A 12-Year, Single-Center Experience

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  14. Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells

    Article • Clinical Immunology, October 2019, Elsevier

    Dr Francisco M Marty

  15. Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature

    Article • Open Forum Infectious Diseases, September 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  16. Herpes Zoster Subunit Vaccination for Renal Transplant Recipients

    Article • Clinical Infectious Diseases, August 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  17. Draft Genome Sequence of Pseudomonas aeruginosa Strain BWH047, a Sequence Type 235 Multidrug-Resistant Clinical Isolate Expressing High Levels of Colistin Resistance

    Article • Microbiology Resource Announcements, July 2019, ASM Journals

    Dr Francisco M Marty

  18. Reply to Aronson et al

    Article • Clinical Infectious Diseases, July 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  19. Five-Year Follow-up after Face Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2019, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  20. A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

    Article • Clinical Infectious Diseases, June 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  21. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?

    Article • Mycoses, April 2019, Wiley

    Dr Francisco M Marty

  22. Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation

    Article • Clinical Infectious Diseases, March 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  23. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, February 2019, Elsevier

    Dr Francisco M Marty

  24. Authors’ Response

    Article • Journal of Thoracic Oncology, November 2018, Elsevier

    Dr Francisco M Marty

  25. 1140. GATA2 Mutations Are Frequently Identified Among Patients With Myeloid Malignancies Who Develop Invasive Aspergillosis

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  26. 1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  27. 1564. Lower Rates of Epstein–Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  28. 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  29. 1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  30. 1730. Outcomes of Patients With Detectable Cytomegalovirus (CMV) DNA at Randomization in the Double-blind, Placebo-Controlled Phase 3 Trial of Letermovir (LET) Prophylaxis for CMV-Seropositive Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  31. 358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  32. 408. Invasive Fungal Petrositis and Carotiditis (IFPAC) Syndrome in Immunocompromised Hosts: An Unrecognized, Often Catastrophic Invasive Fungal Disease (IFD)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  33. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  34. Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

    Article • Blood Advances, August 2018, American Society of Hematology

    Dr Francisco M Marty

  35. Isavuconazole for treatment of rare invasive fungal diseases

    Article • Mycoses, July 2018, Wiley

    Dr Francisco M Marty

  36. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib

    Article • Leukemia & Lymphoma, July 2018, Taylor & Francis

    Dr Francisco M Marty

  37. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection

    Article • Annals of Oncology, July 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  38. Case 5-2018: A Man with Confusion after Stem-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  39. NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation

    Article • Blood Advances, June 2018, American Society of Hematology

    Dr Francisco M Marty

  40. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation

    Article • Blood Advances, June 2018, American Society of Hematology

    Dr Francisco M Marty

  41. Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis

    Article • Biology of Blood and Marrow Transplantation, June 2018, Elsevier

    Dr Francisco M Marty

  42. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation

    Article • PLoS ONE, May 2018, PLOS

    Dr Francisco M Marty

  43. Optical modeling of black silicon using an effective medium/multi-layer approach

    Article • Optics Express, May 2018, Optical Society of America (OSA)

    Dr Francisco M Marty, Professor Diaa Khalil

  44. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial

    Article • Mycoses, April 2018, Wiley

    Dr Francisco M Marty

  45. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species

    Article • Mycoses, April 2018, Wiley

    Dr Francisco M Marty

  46. Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer

    Article • Journal of Thoracic Oncology, April 2018, Elsevier

    Dr Francisco M Marty

  47. Letermovir Prophylaxis for Cytomegalovirus

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  48. Risk of hepatitis B virus reactivation in patients treated with ibrutinib

    Article • Blood, February 2018, American Society of Hematology

    Dr Francisco M Marty

  49. Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, February 2018, Nature

    Dr Francisco M Marty

  50. Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report

    Article • Case Reports in Plastic Surgery and Hand Surgery, January 2018, Taylor & Francis

    Dr Francisco M Marty

  51. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2017, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman, Dr Francisco M Marty

  52. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

    Article • The Oncologist, November 2017, Alphamed Press

    Dr Francisco M Marty

  53. Seasonal Variability Precipitating Hand Transplant Rejection?

    Article • Transplantation, October 2017, Wolters Kluwer Health

    Dr Francisco M Marty

  54. Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid

    Article • Arthritis Care & Research, September 2017, Wiley

    Dr Francisco M Marty

  55. Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, September 2017, Elsevier

    Dr Francisco M Marty

  56. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

    Article • The Journal of Infectious Diseases, June 2017, Oxford University Press (OUP)

    Dr Francisco M Marty

  57. Use of Multimodality Imaging in Diagnosing Invasive Fungal Diseases of the Heart

    Article • Circulation Cardiovascular Imaging, June 2017, Wolters Kluwer Health

    Dr Francisco M Marty

  58. dasatinib increases risk of cytomegalovirus reactivation when used after BMT

    Article • Clinical Infectious Diseases, April 2017, Oxford University Press (OUP)

    Dr Francisco M Marty

  59. mucositis had little impact on isavuconazole absorption

    Article • Antimicrobial Agents and Chemotherapy, March 2017, ASM Journals

    Dr Francisco M Marty

  60. Warm autoimmune hemolytic anemia can develop in patients with babesiosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  61. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

    Article • The Oncologist, February 2017, Alphamed Press

    Dr Francisco M Marty

  62. IV zanamivir was as effective as oral oseltamivir in patients with severe influenza

    Article • The Lancet Respiratory Medicine, February 2017, Elsevier

    Dr Francisco M Marty

  63. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications

    Article • Arthritis & Rheumatology, January 2017, Wiley

    Dr Francisco M Marty

  64. Face Transplantation in a Highly Sensitized Recipient

    Article • Military Medicine, October 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  65. Introducing the Wiley Transplant Peer Review Network

    Article • American Journal of Transplantation, August 2016, Wiley

    Dr Francisco M Marty

  66. The VITAL study: case control studies are hypothesis-generating – Authors' reply

    Article • The Lancet Infectious Diseases, August 2016, Elsevier

    Dr Francisco M Marty

  67. Introducing the Wiley Transplant Peer Review Network

    Article • Transplant International, July 2016, Wiley

    Dr Francisco M Marty

  68. Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study

    Article • Journal of Antimicrobial Chemotherapy, July 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  69. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

    Article • The Lancet Infectious Diseases, July 2016, Elsevier

    Dr Francisco M Marty, Souha Kanj

  70. Introducing The Wiley Transplant Peer Review Network

    Article • Artificial Organs, July 2016, Wiley

    Dr Francisco M Marty

  71. Face Transplantation in a Highly Sensitized Recipient

    Article • Military Medicine, May 2016, AMSUS

    Dr Francisco M Marty

  72. Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation

    Article • Transplant Infectious Disease, April 2016, Wiley

    Dr Francisco M Marty

  73. Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia

    Article • Diagnostic Microbiology and Infectious Disease, March 2016, Elsevier

    Dr Francisco M Marty

  74. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

    Article • Biology of Blood and Marrow Transplantation, February 2016, Elsevier

    Dr Francisco M Marty

  75. Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer

    Article • Infection, January 2016, Springer Science + Business Media

    Dr Francisco M Marty

  76. In Vitro Volatile Metabolite Signatures of Common Pathogenic Fusarium Species

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  77. Norovirus Infection in Transplantation: Prolonged and Morbid Diarrhea

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  78. Scedosporium and lomentospora have unique in vitro VOC profiles

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  79. Safety of Foscarnet (FOS) Treatment for Human Herpesviruses (HHV) in a Contemporary Cohort of Immunocompromised Patients

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  80. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

    Article • PLoS ONE, November 2015, PLOS

    Dr Francisco M Marty

  81. Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors

    Article • Breast Cancer Research and Treatment, September 2015, Springer Science + Business Media

    Dr Francisco M Marty

  82. Cerebrospinal fluidCoccidioidesantigen testing in the diagnosis and management of central nervous system coccidioidomycosis

    Article • Mycoses, September 2015, Wiley

    Dr Francisco M Marty

  83. Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience

    Article • Open Forum Infectious Diseases, July 2015, Oxford University Press (OUP)

    Dr Francisco M Marty

  84. Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

    Article • Arthritis & Rheumatology, May 2015, Wiley

    Dr Francisco M Marty

  85. Initial Experience of Dual Maintenance Immunosuppression With Steroid Withdrawal in Vascular Composite Tissue Allotransplantation

    Article • American Journal of Transplantation, March 2015, Wiley

    Dr Francisco M Marty

  86. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation

    Article • Transplant Immunology, March 2015, Elsevier

    Dr Francisco M Marty

  87. Risk factors for invasive fungal disease in heart transplant recipients

    Article • The Journal of Heart and Lung Transplantation, February 2015, Elsevier

    Dr Francisco M Marty

  88. Decreasing Incidence of Candidemia Without Routine Systemic Antifungal Prophylaxis

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Dr Francisco M Marty

  89. Utility of Sentinel Flaps in Assessing Facial Allograft Rejection

    Article • Plastic & Reconstructive Surgery, January 2015, Wolters Kluwer Health

    Dr Francisco M Marty

  90. A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis

    Article • Clinical Infectious Diseases, October 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  91. Reply to "Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan"

    Article • Journal of Clinical Microbiology, October 2014, ASM Journals

    Dr Francisco M Marty

  92. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

    Article • Blood, September 2014, American Society of Hematology

    Dr Francisco M Marty

  93. Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Article • Annals of Internal Medicine, September 2014, American College of Physicians

    Dr Francisco M Marty

  94. Serologic Response to Hepatitis B Vaccination Among Lung Transplantation Candidates

    Article • Transplantation, September 2014, Wolters Kluwer Health

    Dr Francisco M Marty

  95. Triple opportunistic pulmonary cavitary disease after cord blood transplantation

    Article • Transplant Infectious Disease, August 2014, Wiley

    Dr Francisco M Marty

  96. Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients

    Article • Clinical Microbiology and Infection, August 2014, Elsevier

    Dr Francisco M Marty

  97. The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?

    Article • Transplant Infectious Disease, May 2014, Wiley

    Dr Francisco M Marty

  98. The Management of Antibody-Mediated Rejection in the First Presensitized Recipient of a Full-Face Allotransplant

    Article • American Journal of Transplantation, May 2014, Wiley

    Dr Francisco M Marty

  99. Green Herring Syndrome: Bacterial Infection in Patients With Mucormycosis Cavitary Lung Disease

    Article • Open Forum Infectious Diseases, April 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  100. Long-Term Stability at -20 C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens

    Article • Journal of Clinical Microbiology, April 2014, ASM Journals

    Dr Francisco M Marty

  101. BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis

    Article • Biology of Blood and Marrow Transplantation, April 2014, Elsevier

    Dr Francisco M Marty

  102. Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia

    Article • Clinical Infectious Diseases, March 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  103. Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy

    Article • Journal of Antimicrobial Chemotherapy, February 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  104. Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients

    Article • Biology of Blood and Marrow Transplantation, February 2014, Elsevier

    Dr Francisco M Marty

  105. disseminated mucormycosis treated successfully with isavuconazole

    Article • Journal of Clinical Microbiology, January 2014, ASM Journals

    Dr Francisco M Marty

  106. DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

    Article • Transplant Infectious Disease, January 2014, Wiley

    Dr Francisco M Marty

  107. Cost analysis of dental services needed before hematopoietic cell transplantation

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, January 2014, Elsevier

    Dr Francisco M Marty

  108. Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Dr Francisco M Marty

  109. Ask, Don't Tell — Mobile Phones to Improve HIV Care

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  110. Bradyrhizobium enterica in Cord Colitis Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  111. Incidence and risk factors for herpes zoster following heart transplantation

    Article • Transplant Infectious Disease, October 2013, Wiley

    Dr Francisco M Marty

  112. CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  113. Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

    Article • The Journal of Infectious Diseases, August 2013, Oxford University Press (OUP)

    Dr Francisco M Marty

  114. Sequence-Based Discovery ofBradyrhizobium entericain Cord Colitis Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Aleksandar D Kostic, Dr Francisco M Marty

  115. Postoperative Antibacterial Prophylaxis for the Prevention of Infectious Complications Associated With Tube Thoracostomy in Patients Undergoing Elective General Thoracic Surgery

    Article • JAMA Surgery, May 2013, American Medical Association (AMA)

    Dr Francisco M Marty

  116. Development and Evaluation of a Calibrator Material for Nucleic Acid-Based Assays for Diagnosing Aspergillosis

    Article • Journal of Clinical Microbiology, April 2013, ASM Journals

    Dr Francisco M Marty

  117. Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient

    Article • Neurology, April 2013, Wolters Kluwer Health

    Dr Francisco M Marty

  118. Vascularized composite tissue allotransplantation - state of the art

    Article • Clinical Transplantation, April 2013, Wiley

    Dr Francisco M Marty

  119. Neutropenia Associated With Prolonged Daptomycin Use: Table 1.

    Article • Clinical Infectious Diseases, January 2013, Oxford University Press (OUP)

    Dr Francisco M Marty

  120. Infections Following Facial Composite Tissue Allotransplantation-Single Center Experience and Review of the Literature

    Article • American Journal of Transplantation, December 2012, Wiley

    Dr Francisco M Marty

  121. Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis

    Article • Transplant Infectious Disease, December 2012, Wiley

    Dr Francisco M Marty

  122. Cord-Blood Hematopoietic Stem Cell Transplant Confers an Increased Risk for Human Herpesvirus-6-Associated Acute Limbic Encephalitis: A Cohort Analysis

    Article • Biology of Blood and Marrow Transplantation, November 2012, Elsevier

    Dr Francisco M Marty

  123. InvasiveMycoleptodiscusfungal cellulitis and myositis

    Article • Medical Mycology, October 2012, Oxford University Press (OUP)

    Dr Francisco M Marty

  124. Safety of Posaconazole and Sirolimus Coadministration in Allogeneic Hematopoietic Stem Cell Transplants

    Article • Biology of Blood and Marrow Transplantation, September 2012, Elsevier

    Dr Francisco M Marty

  125. A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation

    Article • Transplantation, August 2012, Wolters Kluwer Health

    Dr Francisco M Marty

  126. Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods

    Article • Journal of Clinical Microbiology, July 2012, ASM Journals

    Dr Francisco M Marty

  127. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study

    Article • Transplant Infectious Disease, June 2012, Wiley

    Dr Francisco M Marty

  128. Infectious Disease Board Review Questions

    Article • June 2012, Oxford University Press (OUP)

    Dr Francisco M Marty

  129. Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

    Article • Clinical Microbiology and Infection, May 2012, Elsevier

    Dr Francisco M Marty

  130. Three Patients with Full Facial Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2012, New England Journal of Medicine (NEJM/MMS)

    Dr. Dennis P Orgill, Dr Francisco M Marty

  131. Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

    Article • Transplant Infectious Disease, February 2012, Wiley

    Dr Francisco M Marty

  132. Serum Galactomannan and (1->3)- -D-Glucan Assays for Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia

    Article • Journal of Clinical Microbiology, December 2011, ASM Journals

    Dr Francisco M Marty

  133. Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?

    Article • Current Opinion in Virology, December 2011, Elsevier

    Dr Francisco M Marty

  134. How Do We Manage Oral Infections in Allogeneic Stem Cell Transplantation and Other Severely Immunocompromised Patients?

    Article • Oral and Maxillofacial Surgery Clinics of North America, November 2011, Elsevier

    Dr Francisco M Marty

  135. Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2011, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  136. Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

    Article • Clinical Infectious Diseases, August 2011, Oxford University Press (OUP)

    Dr Francisco M Marty

  137. Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

    Article • Antimicrobial Agents and Chemotherapy, August 2011, ASM Journals

    Dr Francisco M Marty

  138. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease

    Article • Mycoses, June 2011, Wiley

    Dr Francisco M Marty

  139. Pandemic H1N1 Influenza Infection in Adult Transplant Recipients

    Article • Transplantation, June 2011, Wolters Kluwer Health

    Dr Francisco M Marty

  140. Timeline of Infections after Hematopoietic Stem Cell Transplant

    Article • May 2011, Wiley

    Dr Francisco M Marty

  141. Immune Reconstitution after Myeloablative Stem Cell Transplant

    Article • May 2011, Wiley

    Dr Francisco M Marty

  142. Elevated Serum Beta-d-Glucan Levels in Immunocompromised Children with Clinical Suspicion for Pneumocystis jirovecii Pneumonia

    Article • Clinical and Vaccine Immunology, May 2011, ASM Journals

    Dr Francisco M Marty

  143. Molecular Methods To Improve Diagnosis and Identification of Mucormycosis: Fig. 1.

    Article • Journal of Clinical Microbiology, April 2011, ASM Journals

    Dr Francisco M Marty

  144. HIV-1 and 2009 H1N1 Influenza A in Adults

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

    Dr Francisco M Marty

  145. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

    Article • The Lancet Infectious Diseases, April 2011, Elsevier

    Dr Francisco M Marty

  146. Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

    Article • Biology of Blood and Marrow Transplantation, March 2011, Elsevier

    Dr Francisco M Marty

  147. Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation

    Article • Transplant Infectious Disease, February 2011, Wiley

    Dr Francisco M Marty

  148. Infectious Complications Associated with Immunomodulating Biologic Agents

    Article • Hematology/Oncology Clinics of North America, February 2011, Elsevier

    Dr Francisco M Marty

  149. Gordonia bronchialis Bacteremia and Pleural Infection: Case Report and Review of the Literature

    Article • Journal of Clinical Microbiology, January 2011, ASM Journals

    Dr Francisco M Marty

  150. Invasive Fungal Disease after Remote Inoculation in Transplant Recipients

    Article • Clinical Infectious Diseases, January 2011, Oxford University Press (OUP)

    Dr Francisco M Marty

  151. Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions

    Article • The Journal of Infectious Diseases, November 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  152. Fonsecaea monophoracerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review

    Article • Medical Mycology, August 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  153. Aspergillus DNA contamination in blood collection tubes

    Article • Diagnostic Microbiology and Infectious Disease, August 2010, Elsevier

    Dr Francisco M Marty

  154. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

    Article • Transplant Infectious Disease, July 2010, Wiley

    Dr Francisco M Marty

  155. Invasive fungal disease in patients treated for newly diagnosed acute leukemia

    Article • American Journal of Hematology, July 2010, Wiley

    Dr Francisco M Marty

  156. Infectious Complications Associated with Immunomodulating Biologic Agents

    Article • Infectious Disease Clinics of North America, June 2010, Elsevier

    Dr Francisco M Marty

  157. Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature

    Article • Medical Mycology, May 2010, Oxford University Press (OUP)

    Dr Francisco M Marty, Duane Hospenthal

  158. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, April 2010, ASM Journals

    Dr Francisco M Marty

  159. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

    Article • Journal of Antimicrobial Chemotherapy, April 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  160. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

    Article • Clinical Therapeutics, April 2010, Elsevier

    Dr Francisco M Marty

  161. Infectious Granulomatous Dermatitis Associated With Rothia mucilaginosa Bacteremia: A Case Report

    Article • American Journal of Dermatopathology, April 2010, Wolters Kluwer Health

    Dr Francisco M Marty

  162. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, February 2010, ASM Journals

    Dr Francisco M Marty

  163. Transplant infectious disease as a subspecialty: does outlining how we train define who we are?

    Article • Transplant Infectious Disease, December 2009, Wiley

    Dr Francisco M Marty

  164. Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

    Article • Clinical Infectious Diseases, December 2009, Oxford University Press (OUP)

    Dr Francisco M Marty

  165. Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies

    Article • Academic Radiology, November 2009, Elsevier

    Dr Francisco M Marty

  166. DisseminatedGeotrichum candiduminfection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature

    Article • Transplant Infectious Disease, October 2009, Wiley

    Dr Francisco M Marty

  167. Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, September 2009, Elsevier

    Dr Francisco M Marty

  168. Strongyloideshyperinfection syndrome and transplantation: a preventable, frequently fatal infection

    Article • Transplant Infectious Disease, April 2009, Wiley

    Dr Francisco M Marty

  169. Positively false

    Article • Journal of Hospital Medicine, March 2009, Frontline Medical Communications, Inc.

    Dr Francisco M Marty

  170. Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis

    Article • Medical Mycology, January 2009, Oxford University Press (OUP)

    Dr Francisco M Marty

  171. Human herpesvirus 6 encephalitis

    Article • Current Infectious Disease Reports, July 2008, Springer Science + Business Media

    Dr Francisco M Marty

  172. Recovery of Herbaspirillum Species from Persons with Cystic Fibrosis

    Article • Journal of Clinical Microbiology, June 2008, ASM Journals

    Professor Peter A Vandamme, Dr Francisco M Marty

  173. POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS: CLINICAL FEATURES AND RELATIONSHIP TO HHV6

    Article • Neurology, February 2008, Wolters Kluwer Health

    Dr Francisco M Marty

  174. Persistent and Relapsing Babesiosis in Immunocompromised Patients

    Article • Clinical Infectious Diseases, February 2008, Oxford University Press (OUP)

    Dr Francisco M Marty

  175. chapter reviewing key infectious diseases after hematopoietic-cell transplantation

    Article • January 2008, Springer Science + Business Media

    Dr Francisco M Marty

  176. Management of Oral Infections in Cancer Patients

    Article • Dental Clinics of North America, January 2008, Elsevier

    Dr Francisco M Marty

  177. Posaconazole for Invasive Aspergillosis?

    Article • Clinical Infectious Diseases, September 2007, Oxford University Press (OUP)

    Dr Francisco M Marty

  178. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6

    Article • Neurology, July 2007, Wolters Kluwer Health

    Dr Francisco M Marty

  179. (1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia

    Article • Annals of Internal Medicine, July 2007, American College of Physicians

    Dr Francisco M Marty

  180. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

    Article • Transplant Infectious Disease, June 2007, Wiley

    Dr Francisco M Marty

  181. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

    Article • Blood, March 2007, American Society of Hematology

    Dr Francisco M Marty

  182. Torsades de pointes associated with voriconazole use

    Article • Transplant Infectious Disease, March 2007, Wiley

    Dr Francisco M Marty

  183. Reactivity of (1→3)-β-d-Glucan Assay with Commonly Used Intravenous Antimicrobials

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Dr Francisco M Marty

  184. The persistent challenges of bacterial infections in the transplant recipient

    Article • Transplant Infectious Disease, September 2006, Wiley

    Dr Francisco M Marty

  185. Treatment of Cavitary Pulmonary Zygomycosis With Surgical Resection and Posaconazole

    Article • The Annals of Thoracic Surgery, July 2006, Elsevier

    Dr Francisco M Marty

  186. Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

    Article • Clinical Infectious Diseases, July 2006, Oxford University Press (OUP)

    Dr Francisco M Marty

  187. Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2006, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  188. Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, May 2006, Elsevier

    Dr Francisco M Marty

  189. Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

    Article • Journal of Clinical Microbiology, February 2006, ASM Journals

    Dr Francisco M Marty

  190. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy

    Article • Transplant International, January 2006, Wiley

    Dr Francisco M Marty

  191. Lyme Meningoradiculitis and Myositis after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

    Dr Francisco M Marty

  192. Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin

    Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

    Dr Francisco M Marty

  193. Myiasis Due toDermatobia hominis(Human Botfly)

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  194. Caspofungin versus Liposomal Amphotericin B for Empirical Therapy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  195. Principles of antimicrobial therapy in the transplant patient

    Article • Transplant Infectious Disease, September 2004, Wiley

    Dr Francisco M Marty

  196. Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  197. Disseminated Trichosporonosis Caused by Trichosporon loubieri

    Article • Journal of Clinical Microbiology, November 2003, ASM Journals

    Dr Francisco M Marty

  198. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

    Article • Blood, October 2003, American Society of Hematology

    Dr Francisco M Marty

  199. Antifungal use in HIV infection

    Article • Expert Opinion on Pharmacotherapy, February 2002, Informa Healthcare

    Dr Francisco M Marty

  200. patient with neurosyphilis presented with temporal lobe syndrome

    Article • Clinical Infectious Diseases, April 2001, Oxford University Press (OUP)

    Dr Francisco M Marty